Belgium
# |
Name |
Interest Coverage Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
4.98
|
Dec. 31, 2023 | USD 23.02 | 0.29% |
|
Belgium |
|
2 |
4.33
|
Dec. 31, 2023 | USD 19.60 | -1.02% |
|
Belgium |
|
3 |
4.06
|
Dec. 31, 2023 | USD 191.25 | -1.87% |
|
Belgium |
|
4 |
0.49
|
Dec. 31, 2023 | USD 13.77 | -0.75% |
|
Belgium |
|
5 |
-6.69
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
|
6 |
-6.88
|
Dec. 31, 2023 | USD 2.39 | -3.92% |
|
Belgium |
|
7 |
-36.82
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
The Biotechnology company in Belgium with the highest Interest Coverage Ratio is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at 4.98.
The Biotechnology company in Belgium with the lowest Interest Coverage Ratio is Nyxoah S.A. (NasdaqGM: NYXH) at -36.82.
The top 10 Biotechnology companies in Belgium by Interest Coverage Ratio are Galapagos NV, Fagron NV, UCB SA, Ion Beam Applications SA, MDxHealth SA, Sequana Medical NV and Nyxoah S.A..
The bottom 10 Biotechnology companies in Belgium by Interest Coverage Ratio are Nyxoah S.A., Sequana Medical NV, MDxHealth SA, Ion Beam Applications SA, UCB SA, Fagron NV and Galapagos NV.